
The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs’ original purpose, which was to treat type 2 diabetes, a new study finds. New prescriptions for these drugs have doubled among people who have obesity but not diabetes, investigators found. As a result, drug shortages have… read on > read on >